NEWS

Verily Health Inc., a precision health AI company, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department …

UT Southwestern Medical Center has received an award from the Advanced Research Projects Agency for Health (ARPA-H) to develop livers using patients’ own cells and an innovative three-dimensional (3D) …

Irving-based Celanese Corp., a specialty materials and chemical company, has teamed up with Hong Kong-based VIGOR Precision Ltd., a manufacturer of plastic gears, to develop lightweight plastic joints for …

Dallas-Fort Worth only has 3.3 million square feet of lab space, says Cushman & Wakefield, but that number is expected to multiply in coming years since no less than 61.2 …

“DFW” fares best in workforce size and VC funding, scoring third with 26,000+ jobs and $218 million. The region also finishes sixth among emerging regions in NIH funding. www.genengnews.com/topics/drug-discovery/next-10-u-s-biopharma-clusters/

Addison-based Solenic Medical won a patent for technology that uses alternating magnetic fields to fight infections on metallic medical implants. Its alternating magnetic field technology is at the core of …

Plano-based Secretome Therapeutics has reshaped its leadership team, hiring four executives and moving its chief medical officer into a new role as it heads toward late-stage trials for its lead …

UT Southwestern Medical Center just ranked No. 1 among health care institutions worldwide in the most recent Nature Index rankings for publishing high-quality research across all subjects for the 12-month …

Irving-based Caris Life Sciences began the commercial launch of Caris Detect, a blood test designed to detect signals for multiple types of cancer earlier than previously possible. dallasinnovates.com/caris-life-sciences-begins-commercial-launch-of-multi-cancer-early-detection-blood-test/

dallasinnovates.com/3-life-sciences-companies-expand-pegasus-park-presence-to-towers-top-floor/ The expansions by the companies—CG Oncology, Highlander Health, and LH Capital—are “strengthening the operational bridge that moves medical breakthroughs from the lab to the marketplace,” Pegasus Park said.